FrancophonIA/ELRC3.0 huggingface dataset:
English: When linagliptin plus metformin hydrochloride is used in combination with a sulphonylurea, a lower dose of the sulphonylurea may be required to reduce the risk of hypoglycaemia (see section 4.4).
Danish: Når linagliptin plus metforminhydrochlorid anvendes i kombination med et sulfonylurinstof, kan en lavere dosis af sulfonylurinstof være nødvendig for at reducere risikoen for hypoglykæmi (se pkt.
English: Linagliptin as add-on therapy in elderly (age ≥ 70 years) with type 2 diabetes The efficacy and safety of linagliptin in elderly (age ≥ 70 years) with type 2 diabetes was evaluated in a double-blind study of 24 weeks duration.
Danish: Linagliptin som supplementsbehandling til ældre patienter (alder ≥ 70 år) med type 2-diabetes I et dobbeltblindet 24-ugers studie blev virkningen og sikkerheden af linagliptin 5 mg evalueret hos ældre (≥ 70 år) med type 2-diabetes.
English: Jentadueto is also available in plastic bottles with plastic screw cap and a silica gel desiccant.
Danish: Jentadueto fås også i plastbeholdere med plastskruelåg og silicagel (tørremiddel).
English: Check with your doctor or pharmacist if you are not sure.
Danish: Spørg lægen, apotekspersonalet eller sundhedspersonalet, hvis der er noget, du er i tvivl om.
English: Major adverse cardiovascular events (MACE) and mortality by treatment group in the CAROLINA study
Danish: Tabel 5 Større kardiovaskulære bivirkninger (MACE) og mortalitet pr. behandlingsgruppe i CAROLINA-studiet Linagliptin 5 mg
English: No dose adjustment
Danish: Dosisjustering ikke nødvendig
English: In a 24-week placebo-controlled factorial study of initial therapy, linagliptin 2.5 mg twice daily in combination with metformin (500 mg or 1,000 mg twice daily) provided significant improvements in glycaemic parameters compared with either monotherapy as summarised in Table 3 (mean baseline HbA1c 8.65%).
Danish: I et 24-ugers placebokontrolleret, faktorielt studie af initialbehandling gav linagliptin 2,5 mg 2 gange dagligt i kombination med metformin (500 mg eller 1.000 mg 2 gange dagligt) en signifikant forbedring af glykæmiske parametre sammenlignet med begge former for monoterapi, jf. tabel 3 (gennemsnitligt baseline-HbA1c 8,65 %).
English: Hospitalization for heart failure
Danish: Indlæggelse for hjertesvigt
English: 10 x 1 film-coated tablets 14 x 1 film-coated tablets 28 x 1 film-coated tablets 30 x 1 film-coated tablets 56 x 1 film-coated tablets 60 x 1 film-coated tablets 84 x 1 film-coated tablets 90 x 1 film-coated tablets 98 x 1 film-coated tablets 100 x 1 film-coated tablets 120 x 1 film-coated tablets
Danish: 10 x 1 filmovertrukne tabletter 14 x 1 filmovertrukne tabletter 28 x 1 filmovertrukne tabletter 30 x 1 filmovertrukne tabletter 56 x 1 filmovertrukne tabletter 60 x 1 filmovertrukne tabletter 84 x 1 filmovertrukne tabletter 90 x 1 filmovertrukne tabletter 98 x 1 filmovertrukne tabletter 100 x 1 filmovertrukne tabletter 120 x 1 filmovertrukne tabletter
English: Frequency of adverse reaction
Danish: Hyppighed af bivirkning
English: In humans, independently of its action on glycaemia, metformin hydrochloride has favourable effects on lipid metabolism.
Danish: Hos mennesker har metformin en gunstig indvirkning på lipidmetabolismen - uafhængigt af dets indvirkning på glykæmi.
English: In a pooled analysis of elderly (age ≥ 70 years) patients with type 2 diabetes (n=183) who were taking both metformin and basal insulin as background therapy, linagliptin in combination with metformin plus insulin provided significant improvements in HbA1c parameters with -0.81% (CI: -1.01; -0.61) adjusted mean change from baseline (mean baseline HbA1c 8.13%) compared to placebo in combination with metformin plus insulin.
Danish: I en puljet analyse af ældre patienter (alder ≥ 70 år) med type 2-diabetes (n=183) i behandling med både metformin og basal-insulin gav supplement af linagliptin en signifikant reduktion i HbA1c -parametre med -0,81 % (CI: -1,01; -0,61) justeret gennemsnitlig ændring fra baseline (gennemsnitlig baseline-HbA1c 8,13 %) sammenlignet med placebo.
English: Linagliptin 5 mg showed superiority over 1 mg with regard to trough DPP-4 inhibition (72% vs 32%, p=0.0050) and a numerically larger reduction with regard to adjusted mean change from baseline in HbA1c (-0.63% vs -0.48%, n.s.).
Danish: Linagliptin 5 mg var bedre end 1 mg hvad angår minimumsværdi for DPP-4-hæmning (72 % vs. 32 %, p = 0,0050) og der blev observeret en numerisk større reduktion hvad angår justeret gennemsnitlig ændring fra baseline i HbA1c (-0,63 % vs. -0,48 %, ikke-signifikant).
English: • a significant reduction in the absolute risk of myocardial infarction: metformin 11 events/1,000 patient-years, diet alone 18 events/1,000 patient-years, (p=0.01).
Danish: • en signifikant reduktion af den absolutte risiko for myokardieinfarkt: Metformin 11 hændelser/1.000 patientår, diæt alene 18 hændelser/1.000 patientår, (p=0,01).
English: Patients inadequately controlled on dual combination therapy with the maximal tolerated dose of metformin and a sulphonylurea
Danish: Patienter, der ikke er tilstrækkeligt kontrolleret på dual kombinationsbehandling med maksimal, tolereret dosis af metformin og et sulfonylurinstof
English: Hypoglycaemia (frequency very common (may affect more than 1 in 10 people)) is an identified side effect for the combination of Jentadueto plus sulphonylurea and for the combination Jentadueto plus insulin.
Danish: For lavt blodsukker er en meget almindelig bivirkning (kan forekomme hos mere end 1 ud af 10 patienter) ved behandling med både Jentadueto og et sulfonylurinstof og ved behandling med både Jentadueto og insulin.
English: • a significant reduction of the absolute risk of any diabetes-related complication in the metformin group (29.8 events/1,000 patient-years) versus diet alone (43.3 events/1,000 patient-years), p=0.0023, and versus the combined sulphonylurea and insulin monotherapy groups (40.1 events/1,000 patient-years), p=0.0034,
Danish: • en signifikant reduktion af den absolutte risiko for samtlige diabetesrelaterede komplikationer i metformingruppen (29,8 hændelser/1.000 patientår) vs diæt alene (43,3 hændelser/1.000 patientår), p=0,0023, og vs de kombinerede sulfonylurinstof/insulinmonoterapigrupper (40,1 hændelser/1.000 patientår), p=0,0034,
English: • a significant reduction of the absolute risk of any diabetes-related mortality: metformin 7.5 events/1,000 patient-years, diet alone 12.7 events/1,000 patient-years, p=0.017,
Danish: • en signifikant reduktion af den absolutte risiko for diabetesrelateret mortalitet: Metformin 7,5 hændelser/1.000 patientår, diæt alene 12,7 hændelser/1.000 patientår, p=0,017,
English: The pharmacokinetics of linagliptin has been extensively characterised in healthy subjects and patients with type 2 diabetes.
Danish: Linagliptins farmakokinetik er udførligt undersøgt hos raske frivillige og hos type 2-diabetespatienter.
English: Caution should be exercised in patients with a history of pancreatitis.
Danish: Der skal udvises forsigtighed ved behandling af patienter, der tidligere har haft pankreatitis.
English: Multiple co-administration of 5 mg linagliptin with rifampicin, a potent inductor of P-glycoprotein and CYP3A4, resulted in a 39.6% and 43.8% decreased linagliptin steady-state AUC and Cmax respectively, and about 30% decreased DPP-4 inhibition at trough.
Danish: Gentagen samtidig administration af 5 mg linagliptin og rifampicin, en potent P-glykoprotein- og CYP3A4-induktor, resulterede i en reduktion af steady state-AUC og -Cmax for linagliptin på henholdvis 39,6 % og 43,8 % og en ca. 30 % lavere DPP-4-hæmning ved trough (dalværdi).
English: - Linagliptin belongs to a class of medicines called DPP-4 inhibitors (dipeptidyl peptidase-4
Danish: - Linagliptin tilhører en klasse af lægemidler, der kaldes DPP-4-hæmmere
English: The effective half-life for accumulation of linagliptin, as determined from oral administration of multiple doses of 5 mg linagliptin, is approximately 12 hours.
Danish: Efter oral administration af gentagne doser linagliptin 5 mg er den effektive halveringstid for akkumulering af linagliptin ca. 12 timer.
English: In the overall study observation period adjudicated acute pancreatitis was reported in 0.3% of patients treated with linagliptin and in 0.1% of patients treated with placebo.
Danish: I den samlede studieobserveringsperiode blev der rapporteret adjudikeret akut pankreatitis hos 0,3 % af patienterne i behandling med linagliptin, og hos 0,1 % af patienterne, der fik placebo.
English: Linagliptin in combination with metformin plus insulin provided significant improvements in HbA1c in this subgroup with -0.68% (CI: -0.78; -0,57) adjusted mean change from baseline (mean baseline HbA1c 8.28%) compared to placebo in combination with metformin plus insulin.
Danish: Tripel-kombinationen linagliptin, metformin og insulin medførte en signifikant reduktion i HbA1c i denne undergruppe med -0,68 % (CI: -0,78; -0,57) justeret gennemsnitlig ændring fra baseline (gennemsnitlig baseline-HbA1c 8,28 %) sammenlignet med placebo i kombination med metformin plus insulin.
English: No dose adjustment of linagliptin is recommended in patients with renal impairment; therefore, linagliptin may be continued as a single entity tablet at the same total daily dose of 5 mg if Jentadueto is discontinued due to evidence of renal impairment.
Danish: Derfor kan behandling med linagliptin fortsætte i form af en enkelt tablet ved den samme totale daglige dosis på 5 mg, hvis behandling med Jentadueto seponeres på grund af evidens for nedsat nyrefunktion.
English: Linagliptin as add-on to a combination of metformin and sulphonylurea therapy A placebo-controlled study of 24 weeks in duration was conducted to evaluate the efficacy and safety of linagliptin 5 mg to placebo, in patients not sufficiently treated with a combination with metformin and a sulphonylurea.
Danish: Linagliptin som supplement til metformin og et sulfonylurinstof I et 24-ugers placebokontrolleret studie blev effekten og sikkerheden af linagliptin 5 mg undersøgt hos patienter, der ikke var tilstrækkeligt behandlet med en kombination af metformin og et sulfonylurinstof.
English: As the dose is individually titrated based on glycaemic control, this is of limited clinical relevance.
Danish: Dette er af begrænset klinisk relevans, da doseringen titreres individuelt, baseret på glykæmisk kontrol.
English: Copovidone Magnesium stearate Maize starch
Danish: Copovidon Magnesiumstearat Majsstivelse Kolloid vandfri silica
English: Linagliptin binds very effectively to DPP-4 in a reversible manner and thus leads to a sustained increase and a prolongation of active incretin levels.
Danish: Linagliptin binder reversibelt og meget effektivt til DPP-4.
English: • Disease which may cause tissue hypoxia (especially acute disease, or worsening of chronic disease) such as: decompensated heart failure, respiratory failure, recent myocardial infarction,
Danish: • Sygdom, der kan give vævshypoxi (især akut sygdom eller forværring af kronisk sygdom), f.eks.
English: Film-coated tablet (tablet).
Danish: Filmovertrukket tablet
English: Co-administration of multiple daily doses of 10 mg linagliptin with 850 mg metformin hydrochloride, an OCT substrate, had no relevant effect on the pharmacokinetics of metformin in healthy subjects.
Danish: Samtidig administration af daglige doser på 10 mg linagliptin og 850 mg metformin, et OCT-substrat, havde ingen relevant indvirkning på metformins farmakokinetik hos raske frivillige.
English: Co-administration of multiple doses of linagliptin and metformin did not meaningfully alter the pharmacokinetics of either linagliptin or metformin in healthy volunteers and patients.
Danish: Gentagen samtidig administration af linagliptin og metformin medførte ingen farmakokinetisk ændring af betydning hos raske frivillige eller hos patienter.
English: Plasma AUC of linagliptin increased approximately 33% following 5 mg doses at steady-state compared to the first dose.
Danish: Efter administration af 5 mg doser ved steady state var plasma-AUC for linagliptin ca. 33 % højere i forhold til den første dosis.
English: Co-administration of multiple daily doses of 5 mg linagliptin with multiple doses of 0.25 mg digoxin had no effect on the pharmacokinetics of digoxin in healthy subjects.
Danish: Administration af 5 mg linagliptin sammen med 0,25 mg digoxin dagligt havde ingen indvirkning på digoxins farmakokinetik hos raske frivillige.
English: Pancreatitis rare #
Danish: Pankreatitis sjælden
English: Plasma protein binding of linagliptin is concentration-dependent, decreasing from about 99% at 1 nmol/l to 75-89% at ≥ 30 nmol/l, reflecting saturation of binding to DPP-4 with increasing concentration of linagliptin At high concentrations, where DPP-4 is fully saturated, 70-80% of linagliptin was bound to other plasma proteins than DPP-4, hence 20-30% were unbound in plasma.
Danish: Plasmaproteinbindingen af linagliptin var koncentrationsafhængig og faldt fra ca. 99 % ved 1 nmol/l til 75-89 % ved ≥ 30 nmol/l, hvilket afspejler, at bindingen til DPP-4 blev mættet med stigende koncentrationer af linagliptin.
English: - The active substances are linagliptin and metformin hydrochloride.
Danish: Jentadueto indeholder: - Aktive stoffer: Linagliptin og metforminhydrochlorid.
English: Twice Daily Metformin HCl 1,000 mg Twice Daily
Danish: Linagliptin 2,5 mg to gange dagligt metformin HCl 1.000 mg to gange dagligt
English: • a significant reduction of the absolute risk of overall mortality: metformin 13.5 events/1,000 patient-years versus diet alone 20.6 events/1,000 patient-years, (p=0.011), and versus the combined sulphonylurea and insulin monotherapy groups 18.9 events/1,000 patientyears (p=0.021),
Danish: • en signifikant reduktion af den absolutte risiko for total mortalitet: Metformin 13,5 hændelser/1.000 patientår vs diæt alene 20,6 hændelser/1.000 patientår, (p=0,011), og vs de kombinerede sulfonylurinstof/insulinmonoterapigrupper 18,9 hændelser/1.000 patientår (p=0,021),
English: Co-administration of multiple three-times-daily doses of 850 mg metformin hydrochloride with 10 mg linagliptin once daily did not clinical meaningfully alter the pharmacokinetics of linagliptin in healthy subjects.
Danish: Gentagen samtidig administration af 850 mg metformin tre gange dagligt og 10 mg linagliptin én gang dagligt gav ikke klinisk relevante ændringer i linagliptins farmakokinetik hos raske frivillige.
English: The decrease in body weight with the combination of linagliptin and metformin was similar to that observed for metformin alone or placebo; there was no change in weight from baseline for patients on linagliptin alone.
Danish: Reduktionen i kropsvægt ved en kombination af linagliptin og metformin var den samme som den, der blev observeret med metformin alene eller placebo.
English: With metformin there was no change in AUC, however mean peak serum concentration of metformin was decreased by 18% when administered with food.
Danish: Metformins gennemsnitlige maksimale serumkoncentration var dog reduceret med 18 % ved indtagelse sammen med føde.
English: In the CARMELINA study, bullous pemphigoid was reported in 0.2% of patients treated with linagliptin and in no patient treated with placebo.
Danish: I CARMELINA-studiet blev bulløs pemfigoid rapporteret hos 0,2 % af patienterne i behandling med linagliptin, og hos ingen af de patienter, der fik placebo.
English: Blister: Store in the original package in order to protect from moisture.
Danish: Blister: Opbevares i den originale blister for at beskytte mod fugt.
English: Some medicinal products can adversely affect renal function which may increase the risk of lactic acidosis, e.g. NSAIDs, including selective cyclo-oxygenase (COX) II inhibitors, ACE inhibitors, angiotensin II receptor antagonists and diuretics, especially loop diuretics.
Danish: Dette gælder f.eks. NSAID'er, herunder selektive cyklooxygenase (COX) II-hæmmere, ACE-hæmmere, angiotensin II-receptorantagonister og diuretika, især loop-diuretika.
English: Metformin should be discontinued prior to or at the time of the imaging procedure and not restarted until at least 48 hours after, provided that renal function has been re-evaluated and found to be stable, see sections 4.2 and
Danish: Behandling med metformin skal afbrydes forud for eller på tidspunktet for billeddiagnostiske procedurer og først genoptages mindst 48 timer herefter, forudsat at nyrefunktionen er blevet vurderet og fundet stabil, se pkt.
English: This can lead to serious medical problems like heart disease, kidney disease, blindness, and amputation.
Danish: Når dette sker, ophobes sukker (glucose) i blodet og dette kan føre til alvorlige helbredsproblemer som hjertesygdom, nyresygdom, blindhed og amputation.
English: Jentadueto 2.5 mg/1,000 mg film-coated tablets also contains iron oxide red (E172).
Danish: Jentadueto 2,5 mg/1.000 mg tabletter indeholder også rød jernoxid (E172).
English: For the different doses of metformin, Jentadueto is available in strengths of 2.5 mg linagliptin plus 850 mg metformin hydrochloride and 2.5 mg linagliptin plus 1,000 mg metformin hydrochloride.
Danish: For at kunne opnå forskellige doser af metformin findes Jentadueto i styrkerne 2,5 mg linagliptin plus 850 mg metformin og 2,5 mg linagliptin plus 1.000 mg metformin.
English: Jentadueto is available in perforated unit dose blisters with 10 x 1, 14 x 1, 28 x 1, 30 x 1, 56 x 1, 60 x 1, 84 x 1, 90 x 1, 98 x 1, 100 x 1 and 120 x 1 film-coated tablets and multipacks containing 120 x 1 (2 packs of 60 x 1), 180 x 1 (2 packs of 90 x 1) and 200 x 1 (2 packs of 100 x 1) film-coated tablets.
Danish: Jentadueto fås i perforerede enkeltdosisblistere med 10 x 1, 14 x 1, 28 x 1, 30 x 1, 56 x 1, 60 x 1, 84 x 1, 90 x 1, 98 x 1, 100 x 1 og 120 x 1 filmovertrukne tabletter og multipakninger med 120 x 1 (2 pakninger af 60 x 1), 180 x 1 (2 pakninger af 90 x 1) og 200 x 1 (2 pakninger af 100 x 1) filmovertrukne tabletter.
English: Oval, biconvex, light pink, film-coated tablet of 21.1 mm x 9.7 mm debossed with ”D2/1000" on one side and the company logo on the other.
Danish: Jentadueto 2,5 mg/1.000 mg filmovertrukne tabletter Oval, bikonveks, lyserød, filmovertrukket tablet på 21,1 mm x 9,7 mm, præget med Boehringer Ingelheim logo på den ene side og ”D2/1000” på den anden.
English: Metformin accumulation occurs at acute worsening of renal function and increases the risk of lactic acidosis.
Danish: Ved akut forværring af nyrefunktionen akkumuleres metformin, hvilket øger risikoen for laktatacidose.
English: - High-Density PolyEthylene (HDPE) bottle with plastic screw cap and a seal liner (aluminiumpolyester foil laminate) and a silica gel desiccant.
Danish: - Højdensitetspolyethylen (HDPE)-beholder med plastskruelukning, en tætningspakning (aluminium-polyesterfolielaminat) og silicagel-tørrekapsel.
English: Difference from placebo (adjusted mean) (95% CI) Patients (n, %) achieving HbA1c
Danish: Baseline (gennemsnit) Ændring i forhold til baseline (justeret gennemsnit) Afvigelse fra placebo (justeret gennemsnit) (95 % CI) Patienter (n, %), der opnåede HbA1c < 7 %
English: Continue to take Jentadueto as long as your doctor prescribes it so you can continue to help control your blood sugar.
Danish: Fortsæt med at tage Jentadueto til at kontrollere dit blodsukker, så længe din læge ordinerer det. Din læge kan ordinere dette lægemiddel sammen med en anden slags diabetesmedicin, som tages gennem munden, eller insulin.
English: Patients inadequately controlled on maximal tolerated dose of metformin monotherapy For patients not adequately controlled on metformin alone, the usual starting dose of Jentadueto should provide linagliptin dosed as 2.5 mg twice daily (5 mg total daily dose) plus the dose of metformin already being taken.
Danish: Til patienter, der ikke er tilstrækkeligt kontrolleret på metformin alene, bør den normale startdosis for Jentadueto være 2,5 mg linagliptin 2 gange dagligt (5 mg i alt pr. dag) plus den dosis metformin, som allerede tages.
English: How to take Jentadueto
Danish: Sådan skal du tage Jentadueto
English: Do not use this medicine after the expiry date which is stated on the blister, bottle and carton after EXP.
Danish: Brug ikke Jentadueto efter den udløbsdato, der står på pakningen.
English: Therefore, caution is advised when Jentadueto is used in combination with a sulphonylurea and/or insulin.
Danish: Det er kendt, at sulfonylurinstoffer og insulin kan forårsage hypoglykæmi, og der bør udvises forsigtighed ved anvendelse af Jentadueto i kombination med et sulfonylurinstof og/eller insulin.
English: Urticaria rare
Danish: meget sjælden
English: In case of suspected symptoms, the patient should stop taking metformin and seek immediate medical attention.
Danish: Patienterne skal informeres om at stoppe med at tage metformin og øjeblikkeligt søge lægehjælp ved symptomer, der kan give mistanke om laktatacidose.
English: It is especially important to mention the following: - medicines which increase urine production (diuretics) - medicines used to treat pain and inflammation (NSAID and COX-2-inhibitors, such as ibuprofen and celecoxib) - certain medicines for the treatment of high blood pressure (ACE inhibitors and angiotensin II
Danish: Det er især vigtigt, at du nævner følgende: - Vanddrivende lægemidler (diuretika) - Lægemidler mod smerter og betændelseslignende tilstande (NSAID'er og COX-2-hæmmere,
English: For patients with acute and unstable heart failure, Jentadueto is contraindicated (see section 4.3).
Danish: Jentadueto er kontraindiceret hos patienter med akut og ustabil hjerteinsufficiens (se pkt.
English: Under steady-state conditions, linagliptin exposure in patients with mild renal impairment was comparable to healthy subjects.
Danish: Ved steady state var linagliptin-eksponeringen sammenlignelig hos patienter med let nedsat nyrefunktion og raske frivillige.
English: Jentadueto 2.5 mg/850 mg film-coated tablets also contains iron oxide red (E172) and iron oxide yellow (E172).
Danish: Jentadueto 2,5 mg/850 mg tabletter indeholder også rød jernoxid (E172) og gul jernoxid (E172).
English: Some symptoms need immediate medical attention You should stop taking Jentadueto and see your doctor straight away if you experience the following symptoms of low blood sugar (hypoglycaemia): trembling, sweating, anxiety, blurred vision, tingling lips, paleness, mood change, or confusion.
Danish: Nogle symptomer kræver øjeblikkelig lægehjælp Ved symptomer på for lavt blodsukker (hypoglykæmi) som rysten, svedeture, angst, sløret syn, prikkende fornemmelse på læberne, bleghed, humørsvingninger eller forvirring skal du stoppe med at tage Jentadueto og straks kontakte en læge.
English: The starting dose is at most half of the maximum dose.
Danish: Den maksimale daglige dosis er 1.000 mg Startdosen er højst halvdelen af den maksimale dosis.
English: Remember to take all medicines as directed by your doctor to achieve the best results for your health.
Danish: For at få den bedste virkning skal alle lægemidler tages, som foreskrevet af lægen.
English: - Pack sizes of 10 x 1, 14 x 1, 28 x 1, 30 x 1, 56 x 1, 60 x 1, 84 x 1, 90 x 1, 98 x 1, 100 x 1 and 120 x 1 film-coated tablets and multipacks containing 120 (2 packs of 60 x 1), 180 (2 packs of 90 x 1) and 200 (2 packs of 100 x 1) film-coated tablets in aluminium lidding foil and PVC/polychlorotrifluoro ethylene/PVC based forming foil perforated unit dose blisters.
Danish: - Pakningsstørrelser: 10 x 1, 14 x 1, 28 x 1, 30 x 1, 56 x 1, 60 x 1, 84 x 1, 90 x 1, 98 x 1, 100 x 1 og 120 x 1 filmovertrukne tabletter og multipakninger med 120 (2 pakninger af 60 x 1), 180 (2 pakninger af 90 x 1) og 200 (2 pakninger af 100 x 1) filmovertrukne tabletter.
English: The pharmacokinetics of linagliptin was generally similar in healthy subjects and in patients with type 2 diabetes.
Danish: Linagliptins farmakokinetik hos raske frivillige og type 2-diabetes-patienter var generelt ens.